诺瓦瓦克斯称其疫苗对奥密克戎等变异病毒广泛免疫

华尔街见闻2021-12-23

诺瓦瓦克斯还称，若再打第三针疫苗加强针，对这些新冠变异病毒的免疫效果会加强。其股价盘后先一度跌超8%，而后转涨，涨幅曾超过3%。 美东时间22日周三美股盘后，美国生物科技公司诺瓦瓦克斯公布，初步试验数据显示，针对奥密克戎及其他目前传播的变异毒株，该公司研发的新冠病毒疫苗可以产生广泛的免疫作用。 诺瓦瓦克斯称，在完成共计两针的该司疫苗注射六个月后，若接种者再打第三针加强针，对上述新冠变异病毒的免疫...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Doraemi
    2021-12-23
    Doraemi
    閱
  • 虎琊
    2021-12-23
    虎琊
    Yue
  • Kevin29
    2021-12-23
    Kevin29
    [財迷] 
  • BP小林
    2021-12-23
    BP小林
    [財迷] [財迷] 
  • Bikyi
    2021-12-23
    Bikyi
    漲吧，pls
  • mjng
    2021-12-23
    mjng
    Great
Leave a comment
6